![Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs](https://oncodaily.com/pub/uploads/2024/04/Fz24m0BXgAMyft8-e1712772184895.jpeg)
Photo from Nieves Martinez Lago/X
Apr 14, 2024, 11:39
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter:
“FDA approvals Tumor-Agnostic drugs:
- dMMR
- Pembrolizumab 2017
- Dostarlimab 2022
- MSI-H
- Pembrolizumab 2017
- TMB-High
- Pembrolizumab 2020
- NTRK fusions
- Larotrectinib 2018
- Entrectinib 2019
- BRAF V600E
- Dabrafenib + Trametinib 2022
- RET fusions
- Selpercatinib 2022
- HER2 3+
- T-derutxecan 2024.”
Source: Nieves Martinez Lago/X
Jul 26, 2024, 08:02